Vodafone, AstraZeneca, Amazon and Santander in busy week ahead
Vodafone, Santander, GSK, AstraZeneca and Diageo are among those teeing up a busy week ahead. Vodafone, as its £15 billion merger…
64,000€
-0,39%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AstraZeneca, IIPR, Block, and Crocs and Encourages Investors to Contact the Firm
NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Enhertu approved in US for breast cancer post ET
28 January 2025
Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following…
FDA Expands Label of AZNs Enhertu for New Breast Cancer Indication
The FDA approves AstraZenecas sBLA for Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer in the United States.…
AstraZenecas Enhertu gets additional FDA approval
…